02/28/23 4:05 PMNasdaq : SILK earningsSilk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial OutlookSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2022. “Our fourth quarter closes theRHEA-AIneutral
02/07/23 9:00 AMNasdaq : SILK conferencesearningsSilk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday,RHEA-AIneutral
12/28/22 4:30 PMNasdaq : SILK conferencesSilk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare ConferenceSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Silk RoadRHEA-AIneutral
11/08/22 4:05 PMNasdaq : SILK earningsSilk Road Medical Reports Third Quarter 2022 Financial ResultsSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022. “Our performance in the third quarter reflectsRHEA-AIneutral
11/03/22 4:30 PMNasdaq : SILK conferencesSilk Road Medical to Present at Upcoming Investor Conferences Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences. Stifel 2022 Healthcare ConferenceRHEA-AIneutral
10/25/22 4:30 PMNasdaq : SILK conferencesearningsSilk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2022 after market close on Tuesday, November 8 th, 2022.RHEA-AIneutral
10/18/22 7:46 PMNasdaq : SILK offeringSilk Road Medical Announces Pricing of Public OfferingSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an underwritten public offering of 2,325,582 shares of its common stock at a public offeringRHEA-AIneutral
10/17/22 8:03 PMNasdaq : SILK Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced certain preliminary financial data for the quarter ended September 30, 2022. Summary Preliminary Financial DataRHEA-AIneutral
10/17/22 4:25 PMNasdaq : SILK offeringSilk Road Medical Announces Proposed Public Offering of Common StockSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement of a proposed underwritten public offering of $100 million of shares of its common stock. InRHEA-AIneutral
09/07/22 4:15 PMNasdaq : SILK Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk PatientsSilk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced enrollment of the first patient in ROADSTER 3, the first prospective, multi-center, single-arm study to assessRHEA-AIneutral